Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin

Journal of Nuclear Medicine

Volumn 37, Issue 2, 1996, Pages 343-352

  Kassis, Amin I ^a,b   Jones, Peter L ^a   Matalka, Khalid Z ^a   Adelstein, S James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Shields Warren Radiation Laboratory   (United States)

Author keywords

avidin streptavidin; biotin; monoclonal antibody; signal augmentation; tumor targeting

Indexed keywords

AVIDIN; BIOTIN; MONOCLONAL ANTIBODY; STREPTAVIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BREAST TUMOR; HYBRIDOMA; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

ANIMALS; AVIDIN; BACTERIAL PROTEINS; BIOTIN; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RADIOIMMUNODETECTION; STREPTAVIDIN; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029921429     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Fischman AJ, Khaw BA, Strauss HW. Quo vadis radioimmune imaging? [Editorial]. J Nucl Med 1989;30:1911-1915.
2. Williams LE Let us praise the coherence of nature [Letter]. J Nucl Med 1990;31. 1414-1436
3. Halpern SE, Abdel-Nabi H, Murray JL. Radioimmunoimaging Quo vadis? Toward the imaging of tumor [Letter]. J Nucl Med 1990;31.1436-1438.
4. Massuger L, Claessens R, Kenemans T, Hanselaar T, Corstens F. Nonantigen-specific tissue localization of monoclonal antibodies [Letter] J Nucl Med 1990;31.1438.
5. Mansi L, Lastoria S, Salvatore M, Panza N. Nonspecific uptake in radioimmunoscintigraphy [Letter]. J Nucl Med 1990,31:1438-1439.
6. DeNardo GL, DeNardo SJ Quo vadis radioimmune imaging? [Letter] J Nucl Med 1990 31.1439-1441
7. Kassis AI Optimizing antibodies for use in nuclear medicine [Editorial]. J Nucl Med 1991;32:1751-1753
8. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987;28:1294-1302.
9. Goodwin DA, Meares CF, McCall MJ, McTigue M, Chaovapong W Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. J Nucl Med 1988,29:226-234.
10. Paganelli G, Riva P, Deleide G, et al. In vivo labeling of biotinylated monoclonal antibodies by radioactive avidin a strategy to increase tumor radiolocalization. Int J Cancer Suppl 1988;2 121-125.
11. Pimm MV, Fells HF, Perkins AC, Baldwin RW. Iodine-131 and indium-111-labeled avidin and streptavidin for pre-targetted immunoscintigraphy with biotinylated anti-tumour monoclonal antibody. Nucl Med Commun 1988;9.931-941.
12. Rowlinson G, Rusckowski M, Gionet M, et al Animal tumor localization studies with streptavidin-conjugated antibody and labeled biotin [Abstract]. J Nucl Med 1988,29: 762.
13. 111In BLEDTA-IV clinical imaging in colorectal carcinoma. Antibody Immunoconj Radiopharm 1989,2:1-13
14. Le Doussal J-M, Martin M, Gautherot E, Delaage M, Barbet J. In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate J Nucl Med 1989;30.1358-1366.
15. Paganelli G, Pervez S, Siccardi AG, et al. Intraperitoneal radio-localization of tumors pre-targefed by biotinylated monoclonal antibodies Int J Cancer 1990;45-1184-1189.
16. Paganelli G, Magnani P, Rossetti C, et al. Tumor targeting in patients with ovarian cancer using biotinylated monoclonal antibodies and radioactive streptavidin [Abstract]. J Nucl Med 1990,31.735
17. Le Doussal J-M, Gruaz-Guyon A, Martin M, Gautherot E, Delaage M, Barbet J. Targeting of indium-111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice Cancer Res 1990;50 3445-3452.
18. Kalofonos HP, Rusckowski M, Siebecker DA, et al Imaging of tumor in patterns with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med 1990;31.1791-1796.
19. Paganelli G, Magnani P, Zito F, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res 1991;51 5960-5966.
20. Stickney DR, Anderson LD, Slater JB, et al. Bifunctional antibody, a binary radiopharmaceutical delivery system for imaging colorectal carcinoma. Cancer Res 1991;51:6650-6655.
21. Paganelli G, Malcovati M, Fazio F. Monoclonal antibody pretargetting techniques for tumour localization the avidin-biotin system. Nucl Med Commun 1991;12:211-234.
22. 125I]Iodoaniline: a useful reagent for radiolabeling biotin. Nucl Med Biol 1992,19:297-301.
23. Kuijpers WHA, Bos ES, Kaspersen FM, Veeneman GH, van Boeckel CAA Specific recognition of antibody - oligonucleotide conjugates by radiolabeled antisense nucleotides a novel approach for two-step radioimmunotherapy of cancer. Bioconj Chem 1993;4:94-102.
24. Khawli LA, Alauddin MM, Miller GK, Epstein AL. Improved immunotargeting of tumors with biotinylated monoclonal antibodies and radiolabeled streptavidin Antibody Immunoconj Radiopharm 1993,6.13-27.
25. Hnatowich DJ, Fritz B, Virzi F, Mardirossian G, Rusckowski M. Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody. Nucl Med Biol 1993;20:189-195.
26. Saga T, Weinstein JN, Jeong JM, et al Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin. Cancer Res 1994;54.2160-2165
27. Bos ES, Kuijpers WHA, Meesters-Winters M, et al. In vitro evaluation of DNA-DNA hybridization as a two-step approach in radioimmunotherapy of cancer. Cancer Res 1994,54:3479-3486
28. Green NM. Avidin and streptavidin Methods Enzymol 1990;184:51-67.
29. Bayer EA, Wilchek M. Protein biotinylation. Methods Enzymol 1990;184:138-160
30. Updyke TV, Nicolson GL Immunoaffinity isolation of membrane antigens with biotinylated monoclonal antibodies and immobilized streptavidin matrices. J Immunol Methods 1984,73:83-95
31. Schechter B, Silberman R, Arnon R, Wilchek M Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin. Eur J Biochem 1990;189:327-331
32. Kassis AI. Amplified direction of effector groups to specific target cells in an animal. United States, Australian, Brazilian, Canadian, Chinese, Czechoslovakian, Hungarian, Japanese, South Korean. New Zealand, Polish, Russian, Slovakian, Ukranian and European patents pending, 1993.
33. Starling JJ, Maciak RS, Law KL, et al In vivo antitumor activity of a monoclonal antibody-Vinca alkaloid immunoconjugate directed against a solid tumor membrane antigen characterized by heterogeneous expression and noninternalization of antibody-antigen complexes Cancer Res 1991;51:2965-2972.
34. Starling JJ, Law KL, Hinson NA Internalization studies using a panel of three monoclonal antibodies (MAbs) directed against the human adenocarcinoma-associated antigen. TAG-72. Antibody Immunoconj Radiopharm 1992;5:403-411
35. Carney PL, Rogers PE, Johnson DK Dual isotope study of iodine-125 and indium-111-labeled antibody in athymic mice J Nucl Med 1989,30 374-384.
36. Der-Bahan GP, Gomez B, Masino RS, Parce JW. A fluorometric method for determining the degree of biotinylation of proteins. J Immunol Methods 1990;126. 281-285.
37. Rosebrough SF. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin, and biotin. Nucl Med Biol 1993;20:663-668.
38. Schlom J, Hand PH, Grenier JW, et al. Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting Cancer Res 1990,50(suppl 3):820s-827s.
39. Greiner JW, Guadagni F, Noguchi P, et al. Recombinant interferon enhances monoclonal antibody - targeting of carcinoma lesions in vivo. Science 1987;235.895-898
40. 111In-labeled antimelanoma antibody 96.5 in melanoma patients. J Natl Cancer Inst 1988,80:160-165
41. Khawli LA, Miller GK, Epstein AL. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors Cancer 1994; 73(suppl 3) 824-831
42. LeBerthon B, Khawli LA, Alauddin M, et al Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate Cancer Res 1991;51:2694-2698
43. Green NM. Avidin. Adv Protein Chem 1975,29 85-133.
44. Carrasquillo JA, Mulshine JL, Bunn PA Jr, et al Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma J Nucl Med 1987;28.281-287
45. Sutherland R, Buchegger F, Schreyer M, Vacca A, Mach J-P Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Cancer Res 1987, 47.1627-1633.
46. Fujimori K, Covell DG, Fletcher JE, Weinstein JN A modeling analysis of monoclonal antibody percolation through tumors a binding-site barrier. J Nucl Med 1990;31: 1191-1198
47. Langmuir VK, Atcher RW, Hines JJ, Brechbiel MW. Iodine-125-NRLU-10 kinetic studies and bismuth-212-NRLU-10 toxicity in LS174T multicell spheroids. J Nucl Med 1990,31:1527-1533.
48. Langmuir VK, McGann JK, Buchegger F, Sutherland RM The effect of antigen concentration, antibody valency and size, and tumor architecture on antibody binding in multicell spheroids. Nucl Med Biol 1991;18:753-764.
49. Jam RK, Baxter LT Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res 1988;48:7022-7032.
50. Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res 1990;50(suppl 3):814s-819s.